is farxiga a glp-1 drug TrimRX GLP-1 Drugs and Type 1

References Stanaway JD, et al

However, since STR activation has been reported to upregulate SGLT1 expression [44, 48], it is possible that chronic STR activation may affect GIP secretion via SGLT1 upregulation

Vanessa Mack (Dean) will monitor your progress closely and adjust your treatment as needed to ensure optimal results

GLP-1 (glucagon-like peptide 1) is a hormone produced in the small intestine that stimulates insulin production and inhibits glucagon secretions

GLP-1 therapies are integrated into a broader regimen, and discontinuation is typically considered within the context of overall disease management

However, "better" depends on research objectives